Another State Files Suit Against Lilly
- May 18, 2007
Utah’s Attorney General filed a Zyprexa lawsuit against Eli Lilly and Co. yesterday, making Utah the latest state to join the battle against the drug giant.
The lawsuit, filed by Attorney General Mark Shurtleff, accuses Lilly of promoting Zyprexa for a number of “off-label” (non-FDA approved) uses including treatment of Alzheimer’s, Tourette’s syndrome and anorexia.
Pharmaceutical companies are prevented from marketing drugs for uses not approved by the FDA, although doctors are free to prescribe drugs for non-FDA approved uses if they deem it appropriate.
The state is seeking damages for Zyprexa prescriptions it subsidized through Medicaid.
According to the complaint, Lilly profited at the state’s expense by pushing doctors to prescribe Zyprexa for medically inappropriate and/or unnecessary purposes. The complaint states that Utah paid out “millions of dollars” for needless prescriptions and, as a result, Lilly was “illegally enriched.”
Lilly is currently facing lawsuits filed by seven other state attorney generals, including: Pennsylvania, Montana, Louisiana, West Virginia, Alaska, New Mexico and Mississippi.
Harmed by Zyprexa? It’s not too late to take action. Contact us today to arrange a FREE consultation with an experienced Zyprexa attorney.